367 related articles for article (PubMed ID: 27585353)
41. A patient with TSC1 germline mutation whose clinical phenotype was limited to lymphangioleiomyomatosis.
Sato T; Seyama K; Kumasaka T; Fujii H; Setoguchi Y; Shirai T; Tomino Y; Hino O; Fukuchi Y
J Intern Med; 2004 Aug; 256(2):166-73. PubMed ID: 15257730
[TBL] [Abstract][Full Text] [Related]
42. Lymphangioleiomyomatosis: a review of the literature.
Hancock E; Osborne J
Respir Med; 2002 Jan; 96(1):1-6. PubMed ID: 11863203
[TBL] [Abstract][Full Text] [Related]
43. [Pulmonary lymphangioleiomyomatosis with or without tuberous sclerosis].
Urban T
Rev Mal Respir; 2007 Jun; 24(6):725-40. PubMed ID: 17632432
[TBL] [Abstract][Full Text] [Related]
44. Unilateral lymphangioleiomyomatosis.
Wenaden AE; Copley SJ
J Thorac Imaging; 2005 Aug; 20(3):226-8. PubMed ID: 16077340
[TBL] [Abstract][Full Text] [Related]
45. Severity and outcome of cystic lung disease in women with tuberous sclerosis complex.
Taveira-DaSilva AM; Jones AM; Julien-Williams P; Yao J; Stylianou M; Moss J
Eur Respir J; 2015 Jan; 45(1):171-80. PubMed ID: 25537563
[TBL] [Abstract][Full Text] [Related]
46. [Tuberous sclerosis associated with pulmonary lymphangioleiomyomatosis].
Ju JJ; Lu CC; Perng RP
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jan; 47(1):65-70. PubMed ID: 1848466
[TBL] [Abstract][Full Text] [Related]
47. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis.
Maziak DE; Kesten S; Rappaport DC; Maurer J
Eur Respir J; 1996 Mar; 9(3):402-5. PubMed ID: 8729995
[TBL] [Abstract][Full Text] [Related]
48. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.
Young LR; Vandyke R; Gulleman PM; Inoue Y; Brown KK; Schmidt LS; Linehan WM; Hajjar F; Kinder BW; Trapnell BC; Bissler JJ; Franz DN; McCormack FX
Chest; 2010 Sep; 138(3):674-81. PubMed ID: 20382711
[TBL] [Abstract][Full Text] [Related]
49. [Pulmonary disease in patients with tuberous sclerosis].
Małgorzata S; Maria KK; Jan K
Pneumonol Alergol Pol; 2005; 73(1):48-56. PubMed ID: 16539184
[TBL] [Abstract][Full Text] [Related]
50. Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.
Liu HJ; Krymskaya VP; Henske EP
Chest; 2019 Dec; 156(6):1062-1067. PubMed ID: 31437431
[TBL] [Abstract][Full Text] [Related]
51. Lymphangioleiomyomatosis (LAM) presenting as recurrent pneumothorax in an infant with tuberous sclerosis: treated successfully with sirolimus.
Takia L; Jat KR; Mandal A; Kabra SK
BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413450
[TBL] [Abstract][Full Text] [Related]
52. Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis.
Harari S; Spagnolo P; Cocconcelli E; Luisi F; Cottin V
Curr Opin Pulm Med; 2018 Sep; 24(5):469-476. PubMed ID: 29927757
[TBL] [Abstract][Full Text] [Related]
53. SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS.
Hecimovic A; Jakopovic M; Pavlisa G; Jankovic M; Vukic-Dugac A; Redzepi G; Brcic L; Samarzija M; Gupta N
Lymphology; 2015 Jun; 48(2):97-102. PubMed ID: 26714374
[TBL] [Abstract][Full Text] [Related]
54. [Lymphangioleiomyomatosis - new concepts on pathogenesis, diagnosis and treatment].
Sobiecka M
Wiad Lek; 2016; 69(2 Pt 1):123-9. PubMed ID: 27421126
[TBL] [Abstract][Full Text] [Related]
55. Lymphangioleiomyomatosis, multifocal micronodular pneumocyte hyperplasia, and sarcoidosis: more pathological findings in the same chest CT, or a single pathological pathway?
Di Marco F; Palumbo G; Terraneo S; Imeri G; Lesma E; Sverzellati N; Peron A; Gualandri L; Canevini MP; Centanni S
BMC Pulm Med; 2017 Jul; 17(1):107. PubMed ID: 28754097
[TBL] [Abstract][Full Text] [Related]
56. [Pulmonary lymphangiomyomatosis and tuberous sclerosis--similarities and differences].
Wesołowski S; Meleniewska-Maciszewska A; Szymańska D
Pneumonol Alergol Pol; 1993; 61(3-4):191-6. PubMed ID: 8364437
[TBL] [Abstract][Full Text] [Related]
57. Emerging biomarkers of lymphangioleiomyomatosis.
Nijmeh J; El-Chemaly S; Henske EP
Expert Rev Respir Med; 2018 Feb; 12(2):95-102. PubMed ID: 29171770
[TBL] [Abstract][Full Text] [Related]
58. From the archives of the AFIP: lymphangioleiomyomatosis: radiologic-pathologic correlation.
Abbott GF; Rosado-de-Christenson ML; Frazier AA; Franks TJ; Pugatch RD; Galvin JR
Radiographics; 2005; 25(3):803-28. PubMed ID: 15888627
[TBL] [Abstract][Full Text] [Related]
59. Pulmonary lymphangioleiomyomatosis and tuberous sclerosis complex.
Peccatori I; Pitingolo F; Battini G; Meroni M; Giordano G; Guarino M; Sessa A
Contrib Nephrol; 1997; 122():98-101. PubMed ID: 9399048
[No Abstract] [Full Text] [Related]
60. A rare pulmonary lymphangioleiomyomatosis disease in a male with tuberous sclerosis complex.
Kabi A; Panda S; Sama S; Kumar S; Kaeley N; Sogal P S
Respir Med Case Rep; 2020; 31():101150. PubMed ID: 32695569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
